Trade

with

DepoMed Inc
(NASDAQ: DEPO)
AdChoices
14.88
+0.02
+0.13%
After Hours :
14.88
0.00
0.00%

Open

14.99

Previous Close

14.86

Volume (Avg)

562.88k (1.17M)

Day's Range

14.71-15.07

52Wk Range

7.09-15.51

Market Cap.

870.13M

Dividend Rate ( Yield )

-

Beta

1.54

Shares Outstanding

58.48M

P/E Ratio (EPS)

11.19 (1.33)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 134.21M

    • Net Income

    • 43.31M

    • Market Cap.

    • 870.13M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 35.53

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.54

    • Forward P/E

    • 49.50

    • Price/Sales

    • 3.98

    • Price/Book Value

    • 4.85

    • Price/Cash flow

    • -19.65

      • EBITDA

      • 16.14M

      • Return on Capital %

      • 26.67

      • Return on Equity %

      • 60.25

      • Return on Assets %

      • 26.67

      • Book Value/Share

      • 3.07

      • Shares Outstanding

      • 58.48M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 13.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.07

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 126.10

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • 2,566.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 30.96

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 94.47

            • 64.72

            • Pre-Tax Margin

            • 27.18

            • 13.77

            • Net Profit Margin

            • 35.53

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 93.00

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -1.90

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 3.90

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 2.70

              • 1.52

              • Quick Ratio

              • 2.38

              • 0.87

              • Interest Coverage

              • 4.60

              • 6.77

              • Leverage Ratio

              • 2.56

              • 1.91

              • Book Value/Share

              • 3.07

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 11.17

                • 63.69

                • P/E Ratio 5-Year High

                • 11.67

                • 237.47

                • P/E Ratio 5-Year Low

                • 1.74

                • 19.71

                • Price/Sales Ratio

                • 3.97

                • 3.64

                • Price/Book Value

                • 4.84

                • 3.39

                • Price/Cash Flow Ratio

                • -19.65

                • 21.79

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 60.25

                        (9.50)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • 26.67

                        (6.20)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • 69.10

                        (10.90)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • 256.49k

                      • 27.79k

                      • Inventory Turnover

                      • 1.64

                      • 1.80

                      • Asset Turnover

                      • 0.75

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      9.32M
                      Operating Margin
                      6.94
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -19.65
                      Ownership

                      Institutional Ownership

                      88.01%

                      Top 10 Institutions

                      54.23%

                      Mutual Fund Ownership

                      37.34%

                      Float

                      99.60%

                      5% / Insider Ownership

                      4.14%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • PowerShares Dynamic Pharmaceuticals Port

                      •  

                        2,670,962

                      • 1.23

                      • 4.47

                      • SPDR® S&P Pharmaceuticals ETF

                      •  

                        1,807,312

                      • 0.00

                      • 3.02

                      • iShares Core S&P Small-Cap (AU)

                      •  

                        1,176,415

                      • 0.24

                      • 1.97

                      • Vanguard Total Stock Mkt Idx

                      •  

                        941,657

                      • 0.49

                      • 1.61

                      • iShares Russell 2000 (AU)

                      •  

                        895,020

                      • -0.89

                      • 1.50

                      • iShares Nasdaq Biotechnology

                      •  

                        761,928

                      • -1.85

                      • 1.27

                      • TIAA-CREF Small-Cap Equity

                      •  

                        591,152

                      • 30.85

                      • 1.01

                      • Vanguard Extended Market Index Fund

                      •  

                        552,376

                      • -14.76

                      • 0.94

                      • iShares US Pharmaceuticals

                      •  

                        542,985

                      • 0.00

                      • 0.91

                      • Vanguard Strategic Equity Fund

                      •  

                        524,200

                      • 37.87

                      • 0.90

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • SENVEST INTERNATIONAL LLC

                      •  

                        4,251,330

                      • -4.90%

                      • 7.28

                      • Ingalls & Snyder LLC

                      •  

                        3,977,234

                      • -1.12%

                      • 6.81

                      • State Street Corp

                      •  

                        3,221,591

                      • +70.87%

                      • 5.51

                      • Invesco PowerShares Capital Mgmt LLC

                      •  

                        2,845,855

                      • -3.05%

                      • 4.87

                      • Vanguard Group, Inc.

                      •  

                        2,701,716

                      • +36.97%

                      • 4.62

                      • BlackRock Fund Advisors

                      •  

                        2,621,621

                      • -2.85%

                      • 4.49

                      • Broadfin Capital, LLC

                      •  

                        2,471,692

                      • -22.54%

                      • 4.23

                      • Deltec Asset Management LLC

                      •  

                        2,299,109

                      • -9.33%

                      • 3.93

                      • Millennium Management LLC

                      •  

                        1,060,671

                      • -53.46%

                      • 1.82

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Slow Growth

                      Style

                      Small Growth

                      Depomed, Inc., was incorporated in the State of California on August 7, 1995. The Company is a specialty pharmaceutical company focused on pain and other conditions and diseases of the central nervous system. The Products that compr...moreise its specialty pharmaceutical business are Gralise®, Zipsor® (diclofenac potassium) liquid filled capsules, its non-steriodal anti-inflammatory drug for the treatment of mild to moderate acute pain, CAMBIA®, its non-steriodal anti-inflammatory drug for the acute treatment of migraine attacks, and Lazanda® nasal spray, its product for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. The Company’s operation and business are subjec...moret to a number of other laws and regulations, including those relating to the workplace, privacy, laboratory practices and the purchase, storage, movement, import and export and use and disposal of hazardous or potentially hazardous substances as well as controlled substances.lessless

                      Key People

                      James A. Schoeneck

                      CEO/Director/President

                      Peter D. Staple

                      Chairman of the Board/Director

                      August J. Moretti

                      CFO/Senior VP

                      Mr. Jeff Coon

                      Vice President, Divisional

                      Mr. Steve Greco

                      Vice President, Divisional

                      • DepoMed Inc

                      • 7999 Gateway Boulevard

                      • Newark, CA 94560

                      • USA.Map

                      • Phone: +1 510 744-8000

                      • Fax: +1 650 744-8001

                      • depomedinc.com

                      Incorporated

                      1995

                      Employees

                      308

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: